Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia

Completed

Conditions studied: Parkinson's Disease

In brief

Nearly all Parkinson's disease (PD) patients eventually develop abnormal and unwanted movements (dyskinesias; LID) caused by the gold standard treatment, Levodopa. The severity of these movements can range from subtle to extremely debilitating and may or may not interfere with normal activities such as putting on a coat or brushing ones teeth. The purpose of this study is to demonstrate the validity and reliability of objectively measuring dyskinesia with a forceplate.

Key facts

Study ID

NCT00912977

Run by

Oregon Health and Science University

People needed

10

Starts

2009-06-01

Expected to finish

2010-06-01

Last updated by the study team

2016-09-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Parkinsons disease
• Older than 18

You may not qualify if…

• Must be participating in a Parkinsons disease study at Oregon Health \& Science University

Where it is running

• Oregon Health & Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.